Pathways - manually collected, often from reviews:
OpenBEL Selventa BEL large corpus:
SRC
→
PPA1
(decreases, PPA1 Activity, SRC Activity)
Bondzi et al., Cell Growth Differ 2000* Evidence: we have demonstrated that PP1, a pharmacological inhibitor of Src kinases, blocked SCF-mediated activation of mitogen-activated protein (MAP) kinase, but it also inhibited Kit activation.